Papers - Matsushita, Maiko
-
A Myeloma Cell Line Established from a Patient Refractory to Thalidomide Therapy Revealed High-Risk Cytogenetic Abnormalities and Produced Vascular Endothelial Growth Factor.
Hattori Y, Du W, Yamada T, Ichikawa D, Matsunami S, Matsushita M.
Blood Cancer J 3 e115 2013.05
Research paper (scientific journal), Joint Work, Accepted
-
Chimeric Antigen Receptors Combining 4-1BB and CD28 Signaling Domains Augment PI(3)kinase/AKT/Bcl-X(L) Activation and CD8(+) T Cell-mediated Tumor Eradication.
Zhong XS, Matsushita M*, Plotkin J, Riviere I, Sadelain M.
Mol Ther 18(2) 413-20 2010.02
Research paper (scientific journal), Joint Work, Accepted
-
Genetically targeted T cells eradicate systemic acute lymphoblastic leukemia xenografts.
Brentjens RJ, Santos E, Nikhamin Y, Yeh R, Matsushita M*, La Perle K, Quintás-Cardama A, Larson SM, Sadelain M.
Clin Cancer Res 13 5426-5435 2007.09
Research paper (scientific journal), Joint Work, Accepted
-
Possible involvement of allogeneic antigens recognised by donor-derived CD4 cytotoxic T cells in selective GVL effects after stem cell transplantation of patients with haematological malignancy.
Matsushita M*, Yamazaki R, Ikeda H, Mori T, Sumimoto H, Fujita T, Okamoto S, Ikeda Y, Kawakami Y.
Br J Haematol 132(1) 56-65 2006.01
Research paper (scientific journal), Joint Work, Accepted
-
Identification of bladder cancer antigens recognized by IgG antibodies of a patient with metastatic bladder cancer.
Ito K, Fujita T, Akada M, Kiniwa Y, Tsukamoto M, Yamamoto A, Matsuzaki Y, Matsushita M*, Asano T, Nakashima J, Tachibana M, Hayakawa M, Ikeda H, Murai M, Kawakami Y.
Int J Cancer 108(5) 712-724 2004.02
Research paper (scientific journal), Joint Work, Accepted
-
Identification of bladder cancer antigens recognized by IgG antibodies of a patient with metastatic bladder cancer.
Ito K, Fujita T, Akada M, Kiniwa Y, Tsukamoto M, Yamamoto A, Matsuzaki Y, Matsushita M, Asano T, Nakashima J, Tachibana M, Hayakawa M, Ikeda H, Murai M, Kawakami Y
International Journal of Cancer 108 ( 5 ) 712-724 2004
Research paper (scientific journal), Single Work
-
Preferentially expressed antigen of melanoma (PRAME) in the development of diagnostic and therapeutic methods for hematological malignancies.
Matsushita M*, Yamazaki R, Ikeda H, Kawakami Y.
Leuk Lymphoma 44(3) 439-44 2003.03
Research paper (scientific journal), Joint Work, Accepted
-
Genetic reversion in an acute myelogenous leukemia cell line from a Fanconi anemia patient with biallelic mutations in BRCA2.
Ikeda H, Matsushita M, Waisfisz Q, Kinoshita A, Oostra AB, Nieuwint AW, De Winter JP, Hoatlin ME, Kawai Y, Sasaki MS, D'Andrea AD, Kawakami Y, Joenje H.
Cancer Research 63 ( 10 ) 2688-2694 2003
Research paper (scientific journal), Joint Work, Accepted
-
造血器腫瘍における腫瘍抗原と免疫療法
Matsushita Maiko, Ikeda Hideyuki, Kawakami Yutaka
現代医療 31 ( 5 ) 1155-1160 1999.05
Research paper (scientific journal), Joint Work
-
造血器腫瘍における腫瘍抗原と免疫療法
Matsushita Maiko, Ikeda Hideyuki, Kawakami Yutaka
現代医療 31 ( 5 ) 1155-1160 1999.05
Research paper (scientific journal), Joint Work
-
PRAME protein expressed in leukemia cells as a target molecule for immunotherapy.
池田英之，松下麻衣子，河上裕
Rinsho Ketsueki 40 ( 6 ) 484-486 1999
Research paper (scientific journal), Joint Work
-
造血器腫瘍におけるPRAME
Ikeda Hideyuki, Matsushita Maiko, Kawakami Yutaka
血液・腫瘍科 39 ( 1 ) 46-50 1999
Research paper (scientific journal), Joint Work
-
1,25-Dihydroxyvitamin D3 induces differentiation of a retinoic acid-resistant acute promyelocytic leukemia cell line (UF-1) associated with expression of p21(WAF1/CIP1) and p27(KIP1).
Muto A, Kizaki M, Yamato K, Kawai Y, Kamata-Matsushita M, Ueno H, Ohguchi M, Nishihara T, Koeffler HP, Ikeda Y
Blood 93 ( 7 ) 2225-2233 1999
Research paper (scientific journal), Joint Work, Accepted
-
新しくクローニングされた癌特異抗原―PRAME
Ikeda Hideyuki, Matsushita Maiko
臨床検査 42 ( 7 ) 811-813 1998.07
Research paper (scientific journal), Joint Work